Congressional Republicans Release "Discussion Draft" of Americas Legislation to "Counter China"
Last week, two Republican members of Congress released a discussion draft of a piece of legislation that focuses on trade in the Americas, but has several provisions dealing with China trade issues.
China Releases December Trade Data
China's trade data for December shows that its exports had a larger dip compared to the month before, while the more moderate decline of imports may indicate that economic recovery is on its way. A break down of its trade with major trading partners is provided below.
U.S. House of Representatives Votes To Restrict Sales of Oil from Strategic Petroleum Reserve to China
Last week, the House of Representatives passed a bill that would prohibit sales of oil from the U.S. strategic petroleum reserve to entities linked to the Chinese Communist Party. Prospects for the legislation in the Democrat-controlled Senate are uncertain, however.
CTM Weekly Newsletter
This past week, CTM covered the following issues.
In China:
* Trade negotiations and talks with Ecuador, African countries, and the Philippines
* New requirements for imports of durian imports from the Philippines
* Discussions on compulsory licensing of COVID drugs in China
* Academic review of developments related to government screening of Chinese
China's Foreign Minister Visits Africa, Talks Debt and Other Support
This week, China's new Foreign Minister Qin Gang is visiting Africa to "deepen the China-Africa comprehensive strategic and cooperative partnership and boost friendly cooperation between China and Africa."
More U.S. States Ban TikTok for Government Employees; Senator Calls for Hearing
In the past week, more U.S. states have taken action to prohibit the use of TikTok and other Chinese-linked products and services on state electronic devices. And in Congress, there have been calls for hearings on TikTok.
Paxlovid in China: A Debate on Compulsory Licensing
After the failure by Pfizer and the Chinese government to reach an agreement on including COVID medicine Paxlovid in the state health insurance plan, there are some discussions in China on whether compulsory licensing is justified as cases are surging in the nation.